Scientists are reporting results of the first frontline clinical trial to use targeted therapy to treat high-risk pediatric Hodgkin lymphoma.
People between ages 18 and 29 and those without a high school degree are more likely to experience anxiety or depression during the pandemic and also are least likely to seek mental health treatment, according to a recent report by the Centers for Disease Control and Prevention that surveyed nearly 800,000 households from August 2020 to February 2021.
Despite the dramatic difference between day and nightlife, how fish exploit different times of day has not been studied systematically. Scientists explored alterations in the circadian timing of activity and the duration of rest-wake cycles in Lake Malawi’s cichlids and identified the first single nocturnal species. Timing and duration of rest and activity varies dramatically, and continuously, between populations of Lake Malawi cichlids, providing a system for exploring the molecular and neural basis underlying variation in nocturnal activity.
Whatever ultimately caused inhabitants to abandon Cahokia, it was not because they cut down too many trees, according to new research from Washington University in St. Louis.
Worldwide, 1 in 4 people will suffer from a depressive episode in their lifetime.
While current diagnosis and treatment approaches are largely trial and error, a breakthrough study by Indiana University School of Medicine researchers sheds new light on the biological basis of mood disorders and offers a promising blood test aimed at a precision-medicine approach to treatment.
Racial and ethnic minority groups, low income, underinsured, or uninsured individuals as well as those living in rural areas, often face greater obstacles when it comes to preventing, treating and surviving cancer.
Surprising role for so-called “jumping” genes that are a source of genetic mutations responsible for a number of human diseases.
A dysfunctional immune system significantly contributes to the development of cancer. Several therapeutic strategies to activate the immune system to target cancer cells have been approved to treat different types of cancer, including melanoma.
Twenty-year process involved evaluating malting barley germplasm strains, breeding efforts
MD Anderson and TriSalus announced a strategic research collaboration to evaluate the treatment of liver and pancreas tumors with the investigational therapy SD-101 in combination with immunotherapy using a novel delivery approach.
